(Q37349623)

19 August 2017

1 reference

title

The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies (English)

1 reference

19 August 2017

0 references

0 references

Nisha Bansal

1

1 reference

19 August 2017

Vimala Yendluri

series ordinal

2

1 reference

19 August 2017

Robert M Wenham

series ordinal

3

1 reference

19 August 2017

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

16

1 reference

19 August 2017

8-13

1 reference

19 August 2017

1

1 reference

Novel molecular profiles of endometrial cancer-new light through old windows.

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Molecular carcinogenesis of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Molecular and pathologic aspects of endometrial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Pten, a protean tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Clinical significance of microsatellite instability in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Abnormalities of the APC/beta-catenin pathway in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Targeted therapies in gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Rationale for folate receptor alpha targeted therapy in "high risk" endometrial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480901600102

10.1177/107327480901600102

21 January 2018

Identifiers

DOI

0 references

1 reference